Expanding the scope of the "polypill" to heart failure

J Card Fail. 2013 Aug;19(8):540-1. doi: 10.1016/j.cardfail.2013.05.017.

Authors

Muthiah Vaduganathan¹, Mihai Gheorghiade, Javed Butler

Affiliation

¹ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. [email protected]

PMID: 23910582
DOI: 10.1016/j.cardfail.2013.05.017

No abstract available

Publication types

Review

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / chemistry
Angiotensin-Converting Enzyme Inhibitors / economics
Animals
Antihypertensive Agents / administration & dosage
Antihypertensive Agents / chemistry
Antihypertensive Agents / economics
Cardiotonic Agents / administration & dosage*
Cardiotonic Agents / chemistry
Cardiotonic Agents / economics*
Chemistry, Pharmaceutical
Drug Combinations*
Heart Failure / drug therapy*
Heart Failure / economics*
Humans
Mineralocorticoid Receptor Antagonists / administration & dosage
Mineralocorticoid Receptor Antagonists / chemistry
Mineralocorticoid Receptor Antagonists / economics

Substances

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiotonic Agents
Drug Combinations
Mineralocorticoid Receptor Antagonists